Abstract | BACKGROUND: METHODS: From the Medical Information Mart for Intensive Care (MIMIC)-IV 2.2, 6017 AMI patients were subtracted, and 250 patients with AMI complicated by cardiogenic shock undergoing PCI were analyzed. In-hospital outcomes (death, 24-hour urine volumes, length of ICU stays, and length of hospital stays) and 1-year mortality were compared between IABP and control during the hospital course and 12-month follow-up. RESULTS: An IABP was implanted in 30.8% (77/250) of patients with infarct-related cardiogenic shock undergoing PCI. IABP patients had higher levels of Troponin T (3.94 [0.73-11.85] ng/ml vs. 1.99 [0.55-5.75] ng/ml, p-value = 0.02). IABP patients have a longer length of ICU and hospital stays (124 [63-212] hours vs. 83 [43-163] hours, p-value = 0.005; 250 [128-435] hours vs. 170 [86-294] hours, p-value = 0.009). IABP use was not associated with lower in-hospital mortality (33.8% vs. 33.0%, p-value = 0.90) and increased 24-hour urine volumes (2100 [1455-3208] ml vs. 1915 [1110-2815] ml, p-value = 0.25). In addition, 1-year mortality was not different between the IABP and the control group (48.1% vs. 48.0%; hazard ratio 1.04, 95% CI 0.70-1.54, p-value = 0.851). CONCLUSION: IABP may be associated with longer ICU and hospital stays but not better short-and long-term clinical prognosis.
|
Authors | Dingfeng Fang, Dongdong Yu, Jiabin Xu, Wei Ma, Yuxiang Zhong, Haibo Chen |
Journal | BMC cardiovascular disorders
(BMC Cardiovasc Disord)
Vol. 23
Issue 1
Pg. 425
(08 29 2023)
ISSN: 1471-2261 [Electronic] England |
PMID | 37644466
(Publication Type: Journal Article)
|
Copyright | © 2023. BioMed Central Ltd., part of Springer Nature. |
Topics |
- Humans
- Shock, Cardiogenic
(diagnosis, etiology, therapy)
- Percutaneous Coronary Intervention
(adverse effects)
- Myocardial Infarction
(complications, diagnosis, therapy)
- Heart-Assist Devices
- Hospitals
|